Dorsey & Whitney Trust CO LLC Sells 1,437 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Dorsey & Whitney Trust CO LLC lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 16,160 shares of the pharmacy operator’s stock after selling 1,437 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Walgreens Boots Alliance were worth $151,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. State Street Corp boosted its stake in shares of Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after purchasing an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after buying an additional 2,185,950 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after buying an additional 817,762 shares during the period. Thompson Siegel & Walmsley LLC grew its holdings in Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after acquiring an additional 934,754 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Walgreens Boots Alliance by 9.6% in the fourth quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock valued at $50,684,000 after acquiring an additional 478,061 shares during the period. 58.59% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have commented on the company. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their target price for the company from $11.00 to $9.00 in a report on Friday, February 28th. Truist Financial cut their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Evercore ISI upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Finally, Bank of America lifted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $11.21 on Wednesday. The company has a 50 day simple moving average of $10.71 and a two-hundred day simple moving average of $9.73. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The company has a market capitalization of $9.69 billion, a price-to-earnings ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the business earned $0.66 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.